哈三联上涨5.02%，报16.93元/股

Group 1 - The stock price of Harbin Sanlian Pharmaceutical Co., Ltd. increased by 5.02% on August 1, reaching 16.93 yuan per share, with a trading volume of 76.68 million yuan and a turnover rate of 2.71%, resulting in a total market capitalization of 5.356 billion yuan [1] - Harbin Sanlian, established in 1996, is located in the Limin Development Zone of Harbin and focuses on the research, production, and sales of products in the pharmaceutical, animal health, and wellness sectors, emphasizing quality innovation and refined management [1] - The company has been recognized as a high-tech enterprise and has been listed in the "Top 100 Chinese Chemical Pharmaceutical Enterprises" for six consecutive years [1] Group 2 - As of June 10, Harbin Sanlian had 47,100 shareholders, with an average of 3,673 circulating shares per person [2] - For the first quarter of 2025, Harbin Sanlian reported a revenue of 205 million yuan, a year-on-year decrease of 16.93%, and a net profit attributable to shareholders of -28.8451 million yuan, representing a year-on-year decline of 253.52% [2]